The F.D.A. authorizes Pfizer-BioNTech boosters for children ages 5 to 11.

The Food and Drug Administration authorized booster shots of the Pfizer-BioNTech vaccine on Tuesday for children 5 to 11, the latest in a series of actions intended to bolster waning protection against infection from the coronavirus vaccines.

More than eight million of the 28 million children in that age group in the United States have received two vaccine shots, and will now be eligible for the extra dose at least five months after their second shot. The Centers for Disease Control and Prevention is considered highly likely to recommend the booster dose after an advisory committee of outside experts meets to discuss it on Thursday.

That would make all Americans 5 and older eligible for a booster shot. But booster uptake has been much slower than public health experts hoped; many parents…

Read the Full Article Here nytimes

Spread the love

Leave a Reply Cancel reply